The effects of chemotherapy on cognitive function in a mouse model: A prospective study

Clinical Cancer Research

Volumn 18, Issue 11, 2012, Pages 3112-3121

  Winocur, Gordon ^a,b,g   Henkelman, Mark ^c,d   Wojtowicz, J Martin ^c   Zhang, Haibo ^b,e   Binns, Malcolm A ^a,b   Tannock, Ian F ^f  

^a ROTMAN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f PRINCESS MARGARET HOSPITAL   (Canada)

^g TRENT UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; METHOTREXATE;

ADVERSE OUTCOME; ANIMAL EXPERIMENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISCRIMINATION LEARNING; DRUG EFFECT; EXPERIMENTAL MOUSE; FEMALE; LONG TERM CARE; LONGITUDINAL STUDY; MENTAL TASK; MOUSE; NEUROIMAGING; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; SPATIAL MEMORY; STATE DEPENDENT LEARNING; TASK PERFORMANCE; VISUAL DISCRIMINATION;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COGNITION; DISEASE MODELS, ANIMAL; FEMALE; FLUOROURACIL; LEARNING; LONGITUDINAL STUDIES; MEMORY; METHOTREXATE; MICE; MICE, INBRED BALB C; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 84861763363     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-0060     Document Type: Article

References (34)

1. Ahles TA, Saykin AJ. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 2007;7:192-201.
2. Vardy JS, Rourke S, Tannock IF. Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol 2007;25: 2455-63. (Pubitemid 46999217)
3. van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogle-ever F, et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy. J Natl Cancer Inst 1998;90:210-18. (Pubitemid 28114539)
4. Winocur G, Vardy J, Binns MA, Kerr L, Tannock I. The effects of the anti-cancer drugs, methotrexate and 5-fluorouracil, on cognitive function in mice. Pharmacol Biochem Behav 2006a;85:66-75. (Pubitemid 44802737)
5. Seigers R, Schagen SB, Beerling W, Boogerd W, van Tellingen O, van Dam FS, et al. Long-lasting suppression of hippocampal cell prsoliferation and impaired cognitive performance by methotrexate in the rat." Behav Brain Res 2008;186:168-75. (Pubitemid 350122748)
6. Fardell JE, Vardy J, Logge W, Johnston I. Single high dose treatment with methotrexate causes long-lasting cognitive dysfunction in laboratory rodents. Pharmacol Biochem Behav 2010;97:333-39.
7. Lyons L, El Beltagy M, Umka J, Markwick R, Startin C, Bennett G, et al. Fluoxetine reverses the memory impairment and reduction in proliferation and survival of hippocampal cells caused by methotrexate chemotherapy. Psychopharmacology (Berl) 2011;215:105-15.
8. Mustafa S, Walker A, Bennett G, Wigmore PM. 5-Fluorouracil chemotherapy affects spatial working memory and newborn neurons in the adult rat hippocampus. Eur J Neurosci 2008;28:323-30.
9. Foley JJ, Raffa RB, Walker EA. Effects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory. Psychopharmacology (Berl) 2008;199: 527-38.
10. Ahles TA, Saykin AJ, Furstenberg CT, Cole B, Mott LA, Skalla K, et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 2002;20:485-93. (Pubitemid 34072533)
11. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer 2004;100:2292-99. (Pubitemid 38657875)
12. de Ruiter MB, Reneman L, Boogerd W, Veltman DJ, van Dam FS, Nederveen AJ, et al. Cerebral hyporesponsiveness and cognitive impairment 10 years after chemotherapy for breast cancer. Hum Brain Mapp 2011;32:1206-19.
13. Vardy J, Tannock I. Cognitive function after chemotherapy in adults with solid tumours. Crit Rev Oncol Hematol 2007;63:183-202. (Pubitemid 47126866)
14. Morris RG, Garrud P, Rawlins JN, O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982;297:681-83. (Pubitemid 12096189)
15. Moscovitch M, Winocur G. The frontal cortex and working with memory. In:Stuss DT, Knight RT, editors. Principles of frontal lobe function. London, UK: Oxford University Press; 2002. p. 188-209.
16. Aggleton JP, Hunt PR, Rawlins JN. The effects of hippocampal lesions upon spatial and non-spatial tests of working memory. Behav Brain Res 1986;19:133-46. (Pubitemid 16127880)
17. Winocur G. A comparison of normal old rats and young adult rats with lesions to the hippocampus or prefrontal cortex on a test of matchingto- sample. Neuropsychologia 1992;30:769-81.
18. Winocur G, Wojtowicz JM, Sekeres M, Snyder JS, Wang S. Inhibition of neurogenesis interferes with hippocampus-dependent memory function. Hippocampus 2006b;16:296-304.
19. McDonald RA, Ergis A-M, Winocur G. Functional dissociation of brain regions in learning and memory: evidence for multiple systems. In: Foster JK, Jelicic M, editors. Memory: systems, process, or function. Oxford, UK: Oxford University Press; 1999. p. 66-103.
20. Bock NA, Nieman BJ, Bishop JB, Henkelman RM. In vivo multiple mouse MRI at 7 Tesla. Magn Reson Med 2005;54:1311-16. (Pubitemid 41567215)
21. Spring S, Lerch JP, Henkelman RM. Sexual dimorphismrevealed in the structure of the mouse brain using three-dimensional magnetic resonance imaging. Neuroimage 2007;35:1424-33. (Pubitemid 46561367)
22. Dorr AE, Lerch JP, Spring S, Kabani N, Henkelman RM. High resolution three dimensional brain atlas using an average magnetic resonance imaging of 40 adult C57BL/6J mice. Neuroimage 2008;42:60-69.
23. Shilling V, Jenkins V, Morris R, Deutsch G, Bloomfield D. The effects of adjuvant chemotherapy on cognition in women with breast cancer- preliminary results of an observational longitudinal study. Breast 2005;14:142-50. (Pubitemid 40353042)
24. Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, et al. Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology 2006;15:422-30. (Pubitemid 43826855)
25. Fan HG, Houede-Tchen N, Yi QL, Chemerynsky I, Downie FP, Sabate K, et al. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol 2005;23: 8025-32. (Pubitemid 46657404)
26. Schagen SB, Muller MJ, Boogerd W, Mellenbergh GJ, van Dam FS. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. J Natl Cancer Inst 2006; 98:1742-45. (Pubitemid 44942713)
27. Seigers R, Fardell JE. Neurobiological basis of chemotherapy-induced cognitive impairment: a review of rodent research. Neurosci Biobehav Rev 2011;35:729-41.
28. Fardell JE, Vardy J, Johnston IN, Winocur G. Chemotherapy and Cognitive Impairment: Treatment Options. Clin Pharmacol Ther 2011; 90:366-76.
29. Stuss DT, Robertson IH, Craik FIM, Levine B, Alexander MP, Black S, et al. Cognitive rehabilitation in the elderly: a randomized trial to evaluate a new protocol. J Int Neuropsychol Soc 2007;13:120-31. (Pubitemid 46487383)
30. Anderson ND, Winocur G, Palmer H. Principles of cognitive rehabilitation. In:Gurd J, Kischka U, Marshall J, editors. Handbook of clinical neuropsychology, 2nd ed. Oxford, UK: Oxford University Press; 2010. p. 50-77.
31. Ferguson R J, Ahles TA, Saykin AJ, McDonald BC, Furstenberg CT, Cole BF, et al. Cognitive-behavioral management of chemotherapy-related cognitive change. Psychooncology 2007;16:772-77. (Pubitemid 47249179)
32. Winocur G, Binns MA, Tannock I. Donepezil reduces cognitive impairment associated with anti-cancer drugs in a mouse model. Neuropharmacology 2011;61:1222-28.
33. Schneiderman B. Hippocampal volumes smaller in chemotherapy patients. Lancet Oncol 2004;5:202. (Pubitemid 38391208)
34. Inagaki M, Yoshikawa E, Matsuoka Y, Sugawara Y, Nakano T, Akechi T, et al. Smaller regional volumes of brain gray and white matter demonstrated in breast cancer survivors exposed to adjuvant chemotherapy. Cancer 2007;109:146-56. (Pubitemid 46120202)